FR2433946A1 - Procede pour la preparation d'une solution d'immunglobuline convenant pour l'utilisation par voie intraveineuse - Google Patents

Procede pour la preparation d'une solution d'immunglobuline convenant pour l'utilisation par voie intraveineuse

Info

Publication number
FR2433946A1
FR2433946A1 FR7921345A FR7921345A FR2433946A1 FR 2433946 A1 FR2433946 A1 FR 2433946A1 FR 7921345 A FR7921345 A FR 7921345A FR 7921345 A FR7921345 A FR 7921345A FR 2433946 A1 FR2433946 A1 FR 2433946A1
Authority
FR
France
Prior art keywords
immunglobulin
intravenous use
degrees
preparation
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR7921345A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BLUTSPENDEDIENST LANDESVERBAND
Original Assignee
BLUTSPENDEDIENST LANDESVERBAND
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BLUTSPENDEDIENST LANDESVERBAND filed Critical BLUTSPENDEDIENST LANDESVERBAND
Publication of FR2433946A1 publication Critical patent/FR2433946A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne un procédé pour la préparation une solution d'immunglubiline convenant pour l'utilisation par voie intraveineuse. Conformément à ce procédé, l'on met en suspension par dilution la solution saline d'une immunglobuline avec de l'acide silicique humidifié amorphe, chimiquement pur de granulométrie très fine submicroscopique pour effectuer une purification par adsorption, on règle la suspension à un pH de 6,8 (20 degrés C), la fait incuber entre 30 et 60 minutes sous brassage à environ 20 degrés C, sépare à nouveau l'agent d'adsorption et execute ensuite le même processus avec une valeur de pH de 6,5 (20 degrés C). Ce procedé donne une solution d'immunglobuline pour voie intraveineuse n'entraînant aucun trouble pour le patient.
FR7921345A 1978-08-25 1979-08-24 Procede pour la preparation d'une solution d'immunglobuline convenant pour l'utilisation par voie intraveineuse Pending FR2433946A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782837168 DE2837168A1 (de) 1978-08-25 1978-08-25 Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung

Publications (1)

Publication Number Publication Date
FR2433946A1 true FR2433946A1 (fr) 1980-03-21

Family

ID=6047909

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7921345A Pending FR2433946A1 (fr) 1978-08-25 1979-08-24 Procede pour la preparation d'une solution d'immunglobuline convenant pour l'utilisation par voie intraveineuse

Country Status (7)

Country Link
US (1) US4322403A (fr)
JP (1) JPS5547627A (fr)
AT (1) AT368886B (fr)
DE (1) DE2837168A1 (fr)
FR (1) FR2433946A1 (fr)
GB (1) GB2032437B (fr)
SE (1) SE7906272L (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0085747B2 (fr) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Immunoglobuline humaine pour administration intraveineuse et son procédé de préparation
US4465670A (en) * 1982-07-23 1984-08-14 Dainippon Pharmaceutical Co., Ltd. Method for the treatment of systemic lupus erythematosus and primary glomerulonephritis and agent therefor
DE3310150A1 (de) * 1983-03-21 1984-09-27 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer nebenwirkungsfreien igg-immunglobulinloesung fuer die intravenoese applikation
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals
EP0973384A4 (fr) * 1997-02-13 2004-10-13 Sky High Llc Solution de preservation d'organes
US6962700B1 (en) 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
EP1909831A4 (fr) 2005-06-14 2013-02-20 Amgen Inc Préparations de protéines à tamponnage spontané
US20070049732A1 (en) * 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
US8293242B2 (en) * 2005-09-01 2012-10-23 Plasma Technologies, Llc Ultra-high yield of alpha-1-anti-trypsin
US7879332B2 (en) * 2005-09-01 2011-02-01 Plasma Technologies, Llc Ultra-high yield intravenous immune globulin preparation
EP2182987A4 (fr) * 2007-07-30 2011-11-02 Medacure International Inc Formulation de modulateur de système immunitaire
JP6884858B2 (ja) 2016-10-21 2021-06-09 アムジエン・インコーポレーテツド 医薬製剤及びその製造方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449316A (en) * 1967-03-03 1969-06-10 American Cyanamid Co Process for the purification of gamma globulin employing bentonite
FR7395M (fr) * 1966-04-06 1969-11-03
FR2018394A1 (fr) * 1968-09-19 1970-05-29 Biotest Serum Institut Gmbh
FR2038106A1 (fr) * 1969-04-01 1971-01-08 Upjohn Co
FR2267115A1 (fr) * 1974-04-12 1975-11-07 Merieux Inst
FR2340738A2 (fr) * 1976-02-07 1977-09-09 Plasmesco Ag Procede pour ameliorer la tolerance a l'injection intraveineuse de gammaglobuline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3607857A (en) * 1970-03-03 1971-09-21 Upjohn Co Process of removing acrinol from gamma globulin using siliceous material such as silica gel
US4136094A (en) * 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7395M (fr) * 1966-04-06 1969-11-03
US3449316A (en) * 1967-03-03 1969-06-10 American Cyanamid Co Process for the purification of gamma globulin employing bentonite
FR2018394A1 (fr) * 1968-09-19 1970-05-29 Biotest Serum Institut Gmbh
FR2038106A1 (fr) * 1969-04-01 1971-01-08 Upjohn Co
FR2267115A1 (fr) * 1974-04-12 1975-11-07 Merieux Inst
FR2340738A2 (fr) * 1976-02-07 1977-09-09 Plasmesco Ag Procede pour ameliorer la tolerance a l'injection intraveineuse de gammaglobuline

Also Published As

Publication number Publication date
ATA505279A (de) 1982-04-15
DE2837168A1 (de) 1980-03-06
GB2032437A (en) 1980-05-08
AT368886B (de) 1982-11-25
SE7906272L (sv) 1980-02-26
JPS5547627A (en) 1980-04-04
GB2032437B (en) 1982-10-27
US4322403A (en) 1982-03-30

Similar Documents

Publication Publication Date Title
FR2433946A1 (fr) Procede pour la preparation d'une solution d'immunglobuline convenant pour l'utilisation par voie intraveineuse
US3617545A (en) Removing urea from saline water solutions particularly in an artificial kidney
CA2029021A1 (fr) Alkoxysilanes contenant de la pyridine, lies a des supports inorganiques, et procedes pour leur utilisation permettant d'eliminer et de concentrer des ions particuliers contenus dans des solution
JPS6090847A (ja) 光学導波管のヒドロキシル基含量減少方法
GB1484860A (en) Manufacture of boric acid
GB1519105A (en) Treating of photographic processing solutions
JPS5359254A (en) Method of purifying waste liquid produced from photographic treatment using sulfur bacteria and method of recoveryof silver from waste liquid of photographic treatment
ES427238A1 (es) Un procedimiento para el aclarado de agua para quitar impu-rezas de oxidos de metal, hidroxidos de metal, iones de me- tal e iones fosfato de aguas residuales.
FR2455334A1 (fr) Procede de preparation d'une solution de gallium 68 sous forme ionique
FR2447347A1 (fr) Procede de traitement d'un acide phosphorique impur
SU628804A3 (ru) Способ очистки органических растворов от сопровождающих примесей
MA19421A1 (fr) Procede pour la purification de solutions acides contenant de l'URANIUM
Konduru Absorptive Studies of Aqueous Zinc Ions by Foam Fractionation in Simple Mode
FR2512431B1 (fr) Procede pour la decomposition electrochimique de l'acide nitrique
JP3178080B2 (ja) 抗体の分離精製方法
MA19328A1 (fr) Procede de recuperation de l'uranium (vi) present dans des solutions d'acide phosphorique .
RO89422A (fr) Procede pour la separation de l'arsenic de solutions acides
JPS51130800A (en) Treatment method by exchange,adsorption,separation,enrichment of cesiu m-137 from radio-active waste liquid
US2643210A (en) Vitamin b12-active substance elution from montmorillonite absorbent
JPS57203015A (en) Purifying method of human urinary callicrein
SU1175971A1 (ru) Способ очистки ртути от примесей т желых металлов
FI914760A (fi) Polytetraalkylammonium och polytrialkylamin innehaollande ligander bundna vid oorganiska baerare och foerfarande foer deras anvaendning foer att avlaegsna och koncentrera oenskade joner fraon loesningar.
GB883549A (en) Improvements in and relating to the purification of antihaemophilic globulin
FR2309470A1 (fr) Procede de purification de l'hydroxyde de sodium
RU94035144A (ru) Ионообменный способ очистки скандия и его соединений от примеси циркония